Interstitial pneumonia with autoimmune features: A single center prospective follow-up study

医学 内科学 血清学 免疫学 抗体
作者
Marco Sebastiani,Giulia Cassone,Lisa De Pasquale,Stefania Cerri,Giovanni Della Casa,Caterina Vacchi,Fabrizio Luppi,Carlo Salvarani,Andreina Manfredi
出处
期刊:Autoimmunity Reviews [Elsevier BV]
卷期号:19 (2): 102451-102451 被引量:46
标识
DOI:10.1016/j.autrev.2019.102451
摘要

Recently the term "interstitial pneumonia with autoimmune features" (IPAF) has been proposed to identify patients with interstitial lung disease and autoimmune characteristics, not fulfilling the criteria for specific connective tissue diseases (CTD). Only few data are available about the clinical and serological features of IPAF patients, their survival and the possible evolution in a CTD. The aims of the study were to investigate the demographic and clinico-serologic features of patients with IPAF, their relationship to survival, and the possible evolution in a definite CTD.Fifty-two patients were consecutively enrolled and prospectively followed for 45 ± 31.6 months. Data about disease onset, serological, clinical and therapeutic features, pulmonary function tests and high-resolution computed tomography were periodically repeated. The survival of patients with IPAF was compared with that of 104 patients with idiopathic pulmonary fibrosis (IPF).The clinical domain for IPAF was satisfied in 44 patients, serological domain in 49 and the morphological domain in 29 patients. During the follow-up, a definite CTD was diagnosed in 7 patients, in particular Sjogren's syndrome in 4 patients, rheumatoid arthritis in 2, and polymyositis in the last. The estimated 5-year survival of IPAF patients 69.5 ± 7.8%, significantly higher than survival observed in IPF patients, and the baseline value of FVC and DLCO were the only factors associated to death.IPAF seems to a distinct entity, with a low tendency to evolve in a definite CTD. Nevertheless, further studies are needed to better define the clinical evolution and the outcome of IPAF.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zzh_zxc完成签到,获得积分10
1秒前
2秒前
李爱国的应助被richardhipower采纳,获得10
4秒前
5秒前
Hello的应助被TT采纳,获得10
7秒前
望禾完成签到,获得积分10
7秒前
XX完成签到,获得积分10
10秒前
11秒前
handsomeboy完成签到,获得积分10
12秒前
14秒前
137292967发布了新的文献求助10
15秒前
张磊发布了新的文献求助10
15秒前
15秒前
FashionBoy的应助被richardhipower采纳,获得10
15秒前
田様的应助被Cylara采纳,获得10
17秒前
可爱的函函的应助被yuyuyu采纳,获得10
17秒前
18秒前
无助的考拉完成签到,获得积分10
18秒前
18秒前
18秒前
张张发布了新的文献求助10
19秒前
20秒前
K9999K发布了新的文献求助10
20秒前
Lydia发布了新的文献求助10
20秒前
在水一方的应助被zww采纳,获得10
21秒前
华仔的应助被科研通管家采纳,获得10
21秒前
科目三的应助被科研通管家采纳,获得10
21秒前
烟花的应助被科研通管家采纳,获得10
22秒前
秋风的应助被科研通管家采纳,获得10
22秒前
打打的应助被科研通管家采纳,获得30
22秒前
科研通AI2S的应助被科研通管家采纳,获得10
22秒前
隐形曼青的应助被科研通管家采纳,获得10
22秒前
852的应助被科研通管家采纳,获得10
22秒前
领导范儿的应助被科研通管家采纳,获得10
22秒前
生煎包完成签到,获得积分10
22秒前
完美世界的应助被科研通管家采纳,获得10
22秒前
CAOHOU的应助被科研通管家采纳,获得10
23秒前
今后的应助被科研通管家采纳,获得10
23秒前
Julian的应助被时尚凝海采纳,获得30
23秒前
顺顺利利的应助被科研通管家采纳,获得10
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192604
求助须知:如何正确求助?哪些是违规求助? 9579105
关于积分的说明 21863529
捐赠科研通 7792211
什么是DOI,文献DOI怎么找? 3436974
关于科研通互助平台的介绍 2560633
邀请新用户注册赠送积分活动 2483864